These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23339006)
1. Selected neuroendocrine tumour markers, growth factors and their receptors in typical and atypical bronchopulmonary carcinoids. Telega A; Kos-Kudła B; Foltyn W; Blicharz-Dorniak J; Rosiek V Endokrynol Pol; 2012; 63(6):477-82. PubMed ID: 23339006 [TBL] [Abstract][Full Text] [Related]
2. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms. Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665 [TBL] [Abstract][Full Text] [Related]
3. The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas. Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Rosiek V; Kos-Kudła B Endokrynol Pol; 2012; 63(1):22-8. PubMed ID: 22378094 [TBL] [Abstract][Full Text] [Related]
4. The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression. Filosso PL; Kidd M; Roffinella M; Lewczuk A; Chung KM; Kolasinska-Cwikla A; Cwikla J; Lowczak A; Doboszynska A; Malczewska A; Catalano M; Zunino V; Boita M; Arvat E; Cristofori R; Guerrera F; Oliaro A; Tesselaar M; Buikhuisen W; Kos-Kudla B; Papotti M; Bodei L; Drozdov I; Modlin I Eur J Cardiothorac Surg; 2018 Mar; 53(3):631-639. PubMed ID: 29145657 [TBL] [Abstract][Full Text] [Related]
5. [Effective treatment of a hormonally inactive carcinoid tumour with somatostatin analogues: application of serum chromogranin-A for clinical follow-up]. Igaz P; Rácz K; Tulassay Z Orv Hetil; 2007 Dec; 148(49):2343-6. PubMed ID: 18048114 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids. Besig S; Voland P; Baur DM; Perren A; Prinz C Neuroendocrinology; 2009; 90(4):402-15. PubMed ID: 19816005 [TBL] [Abstract][Full Text] [Related]
7. The role of circulating angiogenic factors in patients operated on for localized malignant melanoma. Bolander A; Wagenius G; Larsson A; Brattström D; Ullenhag G; Hesselius P; Ekman S; Bergqvist M Anticancer Res; 2007; 27(5A):3211-7. PubMed ID: 17970063 [TBL] [Abstract][Full Text] [Related]
8. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. Wang YC; Iezza G; Zuraek MB; Jablons DM; Theodore PR; Bergsland EK; Donner DB; Warren RS; Nakakura EK J Surg Res; 2010 Sep; 163(1):47-51. PubMed ID: 20599218 [TBL] [Abstract][Full Text] [Related]
9. Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis. Donica H; Malecha-Jędraszek A; Strosławska E; Burska A; Szubstarski F Folia Histochem Cytobiol; 2010 Dec; 48(4):603-10. PubMed ID: 21478104 [TBL] [Abstract][Full Text] [Related]
10. Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours. Suresh UR; Wilkes S; Hasleton PS J Clin Pathol; 1991 Jul; 44(7):573-5. PubMed ID: 1713221 [TBL] [Abstract][Full Text] [Related]
11. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I; Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822 [TBL] [Abstract][Full Text] [Related]
12. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia. Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741 [TBL] [Abstract][Full Text] [Related]